Evidence map›Paper›PMID 35386659›Full record

ReviewFrontiers in allergy2022

Mapping Allergic Diseases in Sub-Saharan Africa.

Ofilia Mvoundza Ndjindji, Joel Fleury Djoba Siawaya

Abstract readReview
In one paragraph

Review in Frontiers in allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Daily egg intake may reduce sensitisation to common allergenic foods among six- to nine-month-old south African infants: A randomized controlled trial.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Trial
  2. FAD: a comprehensive database merging information about food allergens.Database : the journal of biological databases and curation · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ofilia Mvoundza NdjindjiService Laboratoire, Unité de Recherche et de Diagnostics Spécialisés, Centre Hospitalier Universitaire Mère-Enfant, Fondation Jeanne EBORI (URDS-CHUMEFJE), Libreville, Gabon.
Joel Fleury Djoba SiawayaService Laboratoire, Unité de Recherche et de Diagnostics Spécialisés, Centre Hospitalier Universitaire Mère-Enfant, Fondation Jeanne EBORI (URDS-CHUMEFJE), Libreville, Gabon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The consensus is that allergic diseases are increasing in Africa. However, this paradigm shift has not yet been translated into practice. Focused on infectious diseases (malaria, tuberculosis, HIV), health policies in Sub-Saharan Africa have often neglected the diagnosis and management of allergies. Allergic disease mapping is crucial to grasp the full extent of Africa's allergic diseases' impact. This mapping will require diverting resources to diagnose and study allergies, even more at the dawn of precision medicine.

Indexed as

Africaallergensallergy-diagnosismapping-allergiesprecise-medicine

Identifiers

PMID35386659
PMCPMC8974792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.